2 false false false false false false false false false false true false false true false true true No description of principal activity 2023-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 6,906 6,906 6,906 xbrli:pure xbrli:shares iso4217:GBP 14632667 2023-03-01 2024-02-29 14632667 2024-02-29 14632667 2023-02-28 14632667 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 14632667 bus:Director1 2023-03-01 2024-02-29 14632667 core:PatentsTrademarksLicencesConcessionsSimilar 2023-03-01 2024-02-29 14632667 core:AfterOneYear 2024-02-29 14632667 core:WithinOneYear 2024-02-29 14632667 core:ShareCapital 2024-02-29 14632667 core:RetainedEarningsAccumulatedLosses 2024-02-29 14632667 core:PatentsTrademarksLicencesConcessionsSimilar 2024-02-29 14632667 bus:SmallEntities 2023-03-01 2024-02-29 14632667 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 14632667 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 14632667 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 14632667 bus:FullAccounts 2023-03-01 2024-02-29 14632667 bus:OrdinaryShareClass1 2024-02-29
COMPANY REGISTRATION NUMBER: 14632667
Trilogy Research Ltd
Filleted Unaudited Financial Statements
29 February 2024
Trilogy Research Ltd
Statement of Financial Position
29 February 2024
2024
Note
£
Fixed assets
Intangible assets
5
6,906
Current assets
Stocks
15,010
Cash at bank and in hand
9,449
--------
24,459
Creditors: amounts falling due within one year
6
1,381
--------
Net current assets
23,078
--------
Total assets less current liabilities
29,984
Creditors: amounts falling due after more than one year
7
31,463
--------
Net liabilities
( 1,479)
--------
Capital and reserves
Called up share capital
8
100
Profit and loss account
( 1,579)
-------
Shareholders deficit
( 1,479)
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Trilogy Research Ltd
Statement of Financial Position (continued)
29 February 2024
These financial statements were approved by the board of directors and authorised for issue on 23 January 2025 , and are signed on behalf of the board by:
Mr G Forster
Director
Company registration number: 14632667
Trilogy Research Ltd
Notes to the Financial Statements
Year ended 29 February 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Bedford Mews, London, N2 9DF.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) No cash flow statement has been presented for the company. (b) Disclosures in respect of financial instruments have not been presented. (c) Disclosures in respect of share-based payments have not been presented. (d) No disclosure has been given for the aggregate remuneration of key management personnel.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets comprise Intellectual Property including Patents and Trade Marks, together with capitalised development costs.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 .
5. Intangible assets
Patents, trademarks and licences
£
Cost
Additions
6,906
-------
At 29 February 2024
6,906
-------
Amortisation
At 1 March 2023 and 29 February 2024
-------
Carrying amount
At 29 February 2024
6,906
-------
6. Creditors: amounts falling due within one year
2024
£
Social security and other taxes
1,381
-------
7. Creditors: amounts falling due after more than one year
2024
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
31,463
--------
8. Called up share capital
Issued, called up and fully paid
2024
No.
£
Ordinary shares of £ 0.0001 each
1,000,000
100
------------
----
9. Controlling party
The company is a wholly-owned subsidiary of Multigate International Limited, a company registered in England & Wales, registration number 02709003, .